Document Detail

Chronic Mitral Regurgitation and Aortic Regurgitation: Have Indications for Surgery Changed?
MedLine Citation:
PMID:  23265342     Owner:  NLM     Status:  Publisher    
The timing of surgery in patients with mitral regurgitation (MR) and aortic regurgitation (AR) continues to elicit uncertainty and considerable controversy. Some patients will incur myocardial structural changes, pulmonary hypertension, or arrhythmias before they manifest symptoms, with the risk that these adverse endpoints will not be reversible after valve repair or replacement. Imaging to assess valve morphology, severity of regurgitation, and left ventricular (LV) volume and function is firmly established, and the guidelines of the American College of Cardiology/American Heart Association and the European Society of Cardiology support this approach. However, with improvement in surgical technique and outcomes, there is momentum toward earlier intervention before patients reach class I indications of symptoms or LV systolic dysfunction, particularly in patients with degenerative MR who are candidates for mitral repair. In expert centers, mitral valve repair is achieved at low risk and with excellent long-term durability of repair, returning patients to a lifespan equivalent to that of the normal population. In AR, decision making is more complex because patients almost invariably require valve replacement. Prospective clinical trials are needed to provide the evidence base for more objective decisions regarding timing of surgery. Biomarkers and new methods to assess interstitial fibrosis and regional myocardial function have also evolved for clinical investigation and hold the promise of enhanced determination of those in whom early surgical intervention is warranted.
Robert O Bonow
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-13
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  -     ISSN:  1558-3597     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Center for Cardiovascular Innovation, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Remnant cholesterol as a causal risk factor for ischemic heart disease.
Next Document:  Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the ...